Aygun C - Search Results

1

Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH).

Sazci A, Ergul E, Aygun C, Akpinar G, Senturk O, Hulagu S. Sazci A, et al. Among authors: aygun c. Cell Biochem Funct. 2008 Apr;26(3):291-6. doi: 10.1002/cbf.1424. Cell Biochem Funct. 2008. PMID: 17563923

2

Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis.

Sazci A, Akpinar G, Aygun C, Ergul E, Senturk O, Hulagu S. Sazci A, et al. Among authors: aygun c. Dig Dis Sci. 2008 Dec;53(12):3218-24. doi: 10.1007/s10620-008-0271-5. Epub 2008 May 9. Dig Dis Sci. 2008. PMID: 18465245

3

Association of nicotinamide-N-methyltransferase gene rs694539 variant with patients with nonalcoholic steatohepatitis.

Sazci A, Ozel MD, Ergul E, Aygun C. Sazci A, et al. Among authors: aygun c. Genet Test Mol Biomarkers. 2013 Nov;17(11):849-53. doi: 10.1089/gtmb.2013.0309. Epub 2013 Aug 21. Genet Test Mol Biomarkers. 2013. PMID: 23964925

4

Genetic variants in the PNPLA3 gene are associated with nonalcoholic steatohepatitis.

Islek EE, Sazci A, Ozel MD, Aygun C. Islek EE, et al. Among authors: aygun c. Genet Test Mol Biomarkers. 2014 Jul;18(7):489-96. doi: 10.1089/gtmb.2014.0019. Epub 2014 May 15. Genet Test Mol Biomarkers. 2014. PMID: 24831885

5

Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease.

Senturk O, Kocaman O, Hulagu S, Sahin T, Aygun C, Konduk T, Celebi A. Senturk O, et al. Among authors: aygun c. Intern Med J. 2008 Mar;38(3):183-9. doi: 10.1111/j.1445-5994.2007.01481.x. Epub 2007 Aug 28. Intern Med J. 2008. PMID: 17725609

6

Clindamycin-induced acute cholestatic hepatitis.

Aygun C, Kocaman O, Gurbuz Y, Senturk O, Hulagu S. Aygun C, et al. World J Gastroenterol. 2007 Oct 28;13(40):5408-10. doi: 10.3748/wjg.v13.i40.5408. World J Gastroenterol. 2007. PMID: 17879418 Free PMC article.

7

Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease.

Aygun C, Kocaman O, Sahin T, Uraz S, Eminler AT, Celebi A, Senturk O, Hulagu S. Aygun C, et al. Dig Dis Sci. 2008 May;53(5):1352-7. doi: 10.1007/s10620-007-9998-7. Epub 2007 Oct 16. Dig Dis Sci. 2008. PMID: 17939039

8

The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia.

Celebi A, Kocaman O, Savli H, Aygün C, Konduk BT, Sentürk O, Hülagu S. Celebi A, et al. Among authors: aygun c. Turk J Gastroenterol. 2009 Sep;20(3):161-4. doi: 10.4318/tjg.2009.0001. Turk J Gastroenterol. 2009. PMID: 19821196 Free article.

9

Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease.

Aygun C, Senturk O, Hulagu S, Uraz S, Celebi A, Konduk T, Mutlu B, Canturk Z. Aygun C, et al. Eur J Gastroenterol Hepatol. 2006 Feb;18(2):175-80. doi: 10.1097/00042737-200602000-00010. Eur J Gastroenterol Hepatol. 2006. PMID: 16394799

10

Endothelial dysfunction in patients with ulcerative colitis.

Kocaman O, Sahin T, Aygun C, Senturk O, Hulagu S. Kocaman O, et al. Among authors: aygun c. Inflamm Bowel Dis. 2006 Mar;12(3):166-71. doi: 10.1097/01.MIB.0000217764.88980.74. Inflamm Bowel Dis. 2006. PMID: 16534416

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters